Stent Thrombosis

David R. Holmes, Dean J. Kereiakes, Scot Garg, Patrick W. Serruys, Gregory J. Dehmer, Stephen G. Ellis, David O. Williams, Takeshi Kimura, David J. Moliterno

Research output: Contribution to journalReview articlepeer-review

323 Scopus citations


Intense investigation continues on the pathobiology of stent thrombosis (ST) because of its morbidity and mortality. Because little advance has been made in outcomes following ST, ongoing research is focused on further understanding predictive factors as well as ST frequency and timing in various patient subsets, depending upon whether a drug-eluting stent or bare-metal stent has been implanted. Although the preventive role of antiplatelet therapies remains unchallenged, new data on genomics and variability in response to antiplatelet therapy, as well as the effects of novel therapeutic agents and duration of therapy, have become available. The goal remains identification of patients at particularly increased risk of ST so that optimal prevention strategies can be developed and employed.

Original languageEnglish (US)
Pages (from-to)1357-1365
Number of pages9
JournalJournal of the American College of Cardiology
Issue number17
StatePublished - Oct 19 2010


  • acute myocardial infarction
  • bare-metal stent
  • drugeluting stent
  • dual antiplatelet therapy
  • percutaneous coronary intervention
  • stent thrombosis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Stent Thrombosis'. Together they form a unique fingerprint.

Cite this